24h Continuous Intraocular Pressure (IOP) Monitoring vs Goldmann Applanation Tonometry

NCT ID: NCT01217853

Last Updated: 2011-08-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-08-31

Study Completion Date

2011-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A study in which intraocular pressure (IOP) will be monitored over 24 hours using the SENSIMED Triggerfish® device and Goldmann applanation tonometry (GAT) in primary open angle glaucoma patients. The aim of this study is to investigate the comparability of diurnal IOP patterns emerging from SENSIMED Triggerfish and GAT.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Open Angle Glaucoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SENSIMED Triggerfish

SENSIMED Triggerfish

Intervention Type DEVICE

Contact lens-based device for continuous intraocular pressure monitoring

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SENSIMED Triggerfish

Contact lens-based device for continuous intraocular pressure monitoring

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed informed consent for the investigation
* Patients with primary open angle glaucoma (POAG), defined as open angle ≥ 30°, confirmed visual field loss (Mean Defect/Least Variance ≤ 2dB) and/or optic nerve head damage (cup disc ratio \> 0,5)
* Age 40-70 years at inclusion
* Not more than 4 diopters spherical equivalent on the study eye
* Not more than 2 diopters cylinder equivalent on the study eye
* For women of childbearing potential, adequate contraception
* Stable anti-glaucomatous therapy 4 weeks before the first 24-hour IOP assessment session and throughout the investigation

Exclusion Criteria

* Patients not able to understand the character and individual consequences of the investigation
* Patients committed to an institution by virtue of an order issued either by the courts or by an authority
* Absence of or withdrawn informed consent
* Patients with contraindications for silicone contact lens wear
* Wear of full frame metallic glasses during SENSIMED Triggerfish monitoring
* Eye disorders including severe dry eye
* Eye disorders secondary to POAG
* Patient who have had ocular surgery within the last 3 months
* Corneal or conjunctival abnormality or irregularity hindering correct contact lens adaptation
* Pregnancy and lactation
* Allergy to oxybuprocaine (ocular anesthesia)
* Simultaneous participation in other clinical research
Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Schlossparkklinik

UNKNOWN

Sponsor Role collaborator

Sensimed AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sensimed AG

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carl Erb, Prof

Role: PRINCIPAL_INVESTIGATOR

Schlosspark-Klinik Berlin

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Schlosspark-Klinik

Berlin, , Germany

Site Status

Johannes Gutenberg Universitätsklinik Mainz

Mainz, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

09/10

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

SENSIMED Triggerfish in Closed Eyes
NCT01938287 COMPLETED PHASE4
SENSIMED Triggerfish
NCT01319604 COMPLETED NA